Compare Research Peptides
Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.
Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.
Matrixyl Palmitoyl Pentapeptide-4 | Argireline Acetyl Hexapeptide-8 | |
|---|---|---|
| Evidence Grade | CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data | CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data |
| Regulatory | Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only | Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only |
| Category | Cosmetic & Topical | Cosmetic & Topical |
| Key Benefits |
|
|
| Dosage | 2-5% % | 5-10% % |
| Frequency | 1-2x daily | 2x daily |
| Administration | Topical | Topical |
| Mechanism | Palmitoyl Pentapeptide-4, a signal peptide that stimulates collagen and fibronectin production. One of the most well-studied cosmetic peptides for anti-aging skincare. | Acetyl Hexapeptide-8 (now called Acetyl Hexapeptide-3), a topical peptide that mimics the N-terminal end of SNAP-25 to reduce muscle contraction and diminish expression lines. Known as 'topical Botox alternative'. |
| Side Effects / Risks |
|
|
| Research Status | Moderate Clinical Data | Moderate Clinical Data |
Palmitoyl Pentapeptide-4
Cosmetic & TopicalDosage
2-5% %, 1-2x daily
Administration
Key Benefits
Side Effects
Research Status
Moderate Clinical Data
Acetyl Hexapeptide-8
Cosmetic & TopicalDosage
5-10% %, 2x daily
Administration
Key Benefits
Side Effects
Research Status
Moderate Clinical Data